U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07803770) titled 'EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer' on April 22.
Brief Summary: The EUS-AI-R study is an observational, single-center, two-phase (retrospective-prospective) study designed to develop and validate artificial intelligence (AI) models for predicting chemotherapy response and oncological outcomes in patients with pancreatic ductal adenocarcinoma (PDAC).
Patients who underwent endoscopic ultrasound (EUS) with tissue acquisition (EUS-FNA/FNB) for suspected pancreatic lesions at IRCCS San Raffaele Hospital between January 1st, 2019 and January 2026 will be retrospectively included. All patients have...